Red flags include significantly lower prices than market average, reluctance to provide CoAs or facility information, vague or evasive answers about sourcing and manufacturing, poor packaging quality, spelling errors on labels, lack of batch numbers or expiration dates, and suppliers with very short operational histories or inconsistent online reviews
Who is leaning into GLP-1 specifics in 2026
Multifactorial intervention to reduce cardiovascular disease in type 1 diabetes
It helps the body produce and replenish white blood cells, particularly lymphocytes, which produce antibodies to fight infections
GLP-1 receptor agonist medications are typically used to treat type 2 diabetes and obesity, although their use is expanding to other health conditions
They developed all of the abnormal behaviors associated with anorexia, bulimia, and binge-eating disorder